Search

Your search keyword '"Stagni, S."' showing total 516 results

Search Constraints

Start Over You searched for: Author "Stagni, S." Remove constraint Author: "Stagni, S."
516 results on '"Stagni, S."'

Search Results

1. Does multiparametric (mp) MRI and MRI-informed biopsy improve risk allocation of men at inclusion in active surveillance for low-risk prostatic cancer? Results of per-protocol population of the prospective single institution SPRINT trial

2. Organ preservation and oncological efficacy of peniscopically controlled CO2 laser excision of penile squamous cell carcinoma: Early and late results in a high-volume center

3. 12P Do retroperitoneal extragonadal germ cell tumours (pR-GCT) exist? Evaluation of treatment outcomes of an international retrospective collaboration (PRIMERE study-IGG05)

4. Primary retroperitoneal germ-cell tumors (pR-GCT): Evaluation of treatment outcomes of an international collaboration (PRIMERE study-IGG05)

5. Grade reclassification during active surveillance in low risk prostate cancer men selected with an MRI-informed biopsy

6. Active surveillance for very small renal masses: Analysis from an observational prospective trial (NCT03804320)

8. High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study

9. Bilateral inguinal lymph-node dissection versus unilateral inguinal lymph-node dissection and contralateral dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis

12. Surgical and oncological outcomes of post chemotherapy laparoscopic retroperitoneal lymph node dissection in stage IIA-III non seminomatous germ-cell tumors

13. A0822 - Does multiparametric (mp) MRI and MRI-informed biopsy improve risk allocation of men at inclusion in active surveillance for low-risk prostatic cancer? Results of per-protocol population of the prospective single institution SPRINT trial

15. A0041 - Primary retroperitoneal germ-cell tumors (pR-GCT): Evaluation of treatment outcomes of an international collaboration (PRIMERE study-IGG05)

18. Renal tumor biopsy (RTB) in patients with cT1b-t4-m0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management.

22. Dynamic sentinel node biopsy for clinical N0 squamous cell penile carcinoma: a large, contemporary analysis

23. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: evaluation of safety and efficacy of open and laparoscopic procedures

24. Dynamic sentinel node biopsy versus observation in clinical N0 penile squamous cell carcinoma: a large tertiary national referral center experience

25. Determinants of inguinal lymph node involvement and predicted rates of inguinal nodal disease in clinical N0 penile squamous cell carcinoma patients

26. Active surveillance for small renal masses: a prospective translational study update (NCT03804320)

28. A predictive model to personalize follow up schedules for patients in active surveillance

31. Favourable and reliable PSA doubling time can improve confidence in reducing the number of repeat biopsy during active surveillance

32. Reclassification due to upgrading during active surveillance protocols in low risk prostatic cancer: The role of number of repeat biopsies in the long terms

33. Do number of biopsies and PSA doubling time at 3 and 5 years in active surveillance protocols associate with upgrading reclassification?

34. Active surveillance for small renal masses ≤2cm: Results from an Italian multi-institutional prospective protocol

35. Primary retroperitoneal lymph-node dissection (RPLND) in stage IIA/IIB germ-cell tumours (GCT) of the testis: Is it an effective and safe approach in modern setting?

38. Photophysical and biological investigation of phenol substituted rhenium tetrazolato complexes

42. Search for the suppressed decays B+→K+K+π− and B+→π+π+K−

43. Highly conjugated blue dimers of platinum(II)

45. Clinical Results for an Active Surveillance Cohort with Localized Prostate Cancer Receiving RT after Exiting Active Surveillance

46. Effect of number of computed tomography (CT) scans during follow-up (FUP) of patients with clinical stage I (CSI) seminoma: A trial-level meta-analysis

47. Active surveillance in prostate cancer patients: Predicting the chance of continuing AS after re-biopsy

48. Lipid profiles of prostate cancer cells

49. Luminescent protein staining with Re(i) tetrazolato complexes

50. Probing the effect of ß-triketonates in visible and NIR emitting lanthanoid complexes

Catalog

Books, media, physical & digital resources